The Battle of Paris: How Esma Fought to Save Mifid II

For four years, regulators had to face fierce objections from groups of market participants that were unhappy with new European rules.

Mifid tredline
Over the course of four years, several Mifid II provisions were challenged.

The Mifid II journey has not been an easy ride, either technically or politically, for both market participants and regulators. The job has been particularly tough for the European Securities and Markets Authority, a comparatively tiny regulator—its headcount and budget are dwarfed by the national regulators it technically oversees—which was nonetheless given the somewhat thankless task of fleshing out the package of rules via technical standards and official opinions.

It has faced opposition

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here